Trial Profile
Effects of Intervention With the Glucagon-like Peptide 1 (GLP-1) Analog Liraglutide Plus Metformin Versus Metformin Monotherapy in Overweight/Obese Women With Metabolic Defects and Recent History of Gestational Diabetes Mellitus (GDM)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Metformin
- Indications Gestational diabetes
- Focus Therapeutic Use
- 19 Jul 2019 Status changed from active, no longer recruiting to completed.
- 25 Apr 2019 Planned End Date changed from 1 Aug 2019 to 1 Jun 2019.
- 21 Mar 2018 Planned End Date changed from 1 Jun 2019 to 1 Aug 2019.